VANCOUVER, BC, April 2, 2024 /CNW/ - Filament Health Corp. , a clinical-stage natural psychedelic drug development company, released its fourth quarter financial results and operational highlights.
Filament Health highlights botanical psilocybin drug candidate s progress in 4Q proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.